L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 319-323

  Szefel, Jarosław ^a   Kruszewski, Wiesław Janusz ^a,b   Ciesielski, Maciej ^a,b   Szajewski, Mariusz ^a,b   Kawecki, Krzysztof ^a   Aleksandrowicz Wrona, Ewa ^b   Jankun, Jerzy ^c,d   Łysiak SzydŁowska, Wiesława ^e  

^a Department of Surgical Oncology   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e Powi lanski College of Kwidzy   (Poland)

Author keywords

Cancer cachexia; Fatty acid; L carnitine; Lipid emulsion

Indexed keywords

CARNITINE; LIPID; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMULSION; FEMALE; HUMAN; HUMAN TISSUE; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; REFERENCE VALUE; SKELETAL MUSCLE; TOTAL PARENTERAL NUTRITION; URINARY EXCRETION;

AGED; BODY MASS INDEX; CACHEXIA; CARNITINE; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEOPLASMS; REFERENCE VALUES; TRIGLYCERIDES;

EID: 84861558882     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1804     Document Type: Article

References (29)

1. Alberty R and Albertyova D: Biological variation of free and total carnitine in serum of healthy subjects. Clin Chem 43: 2441-2443, 1997.
2. Marin VB, Azocar M, Molina M, Guerrero JL, Ratner R and Cano F: Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients. Adv Perit Dial 22: 130-135, 2006.
3. Locasale JW and Cantley LC: Altered metabolism in cancer. BMC Biol 8: 88, 2010.
4. Hsu PP and Sabatini DM: Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707, 2008.
5. Fouladiun M, Körner U, Bosaeus I, Daneryd P, Hyltander A and Lundholm KG: Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care - correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 103: 2189-2198, 2005. (Pubitemid 40605128)
6. Fearon K, Strasser F, Anker SD, et al: Definition and classifi- cation of cancer cachexia: an international consensus. Lancet Oncol 12: 489-495, 2011.
7. Agustsson T, Ryden M, Hoffstedt J, et al: Mechanism of increased lipolysis in cancer cachexia. Cancer Res 67: 5531-5537, 2007. (Pubitemid 46997295)
8. Rasmussen BB, Holmback UC, Volpi E, Morio-Liondore B, Paddon-Jones D and Wolfe RR: Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest 110: 1687-1693, 2002. (Pubitemid 35424247)
9. Saks V, Favier R, Guzun R, Schlattner U and Wallimann T: Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands. J Physiol 577: 769-777, 2006. (Pubitemid 44873644)
10. Peluso G, Nicolai R, Reda E, Benatti P, Barbarisi A and Calvani M: Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol 182: 339-350, 2000. (Pubitemid 30054367)
11. Mancinelli A, D'Iddio S, Bisonni R, Graziano F, Lippe P and Calvani M: Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment. Cancer Chemother Pharmacol 60: 19-26, 2007. (Pubitemid 46643713)
12. McGough C, Baldwin C, Frost G and Andreyev HJ: Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer 90: 2278-2287, 2004. (Pubitemid 38961889)
13. Pezner R and Archambeau JO: Critical evaluation of the role of nutritional support for radiation therapy patients. Cancer 55: 263-267, 1985. (Pubitemid 15155452)
14. Cederblad G, Harper P and Lindgren K: Spectrophotometry of carnitine in biological fluids and tissue with a Cobas Bio centrifugal analyzer. Clin Chem 32: 342-346, 1986. (Pubitemid 17025655)
15. Sałek J, Mierzejewski P, Wa̧sewicz M, Uszycka-Karcz M and Łysiak-Szydłowska W: Karnityna surowicy i moczu, próba monitorowania terapii karnityna̧. Diagn Lab 25: 109-118, 1989 (In Polish).
16. Debska S, Kawecka A, Wojnarowski K, et al: Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients. Int J Artif Organs 23: 90-96, 2000. (Pubitemid 30192762)
17. Rebouche CJ and Engel AG: Tissue distribution of carnitine biosynthetic enzymes in man. Biochim Biophys Acta 630: 22-29, 1980. (Pubitemid 10019432)
18. Rebouche CJ: Sites and regulation of carnitine biosynthesis in mammals. Fed Proc 41: 2848-2852, 1982.
19. Malaguarnera M, Risino C, Gargante MP, et al: Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia. World J Gastroenterol 12: 4541-4545, 2006. (Pubitemid 44256342)
20. Eanes RZ and Biniek RL: The twenty-four-hour urinary excretion of carnitine and creatinine in normal and hypothyroid children. Biochem Med 24: 110-117, 1980. (Pubitemid 11238896)
21. Evans AM and Fornasini G: Pharmacokinetics of L-carnitine. Clin Pharmacokinet 42: 941-967, 2003. (Pubitemid 37056103)
22. Acharyya S, Ladner KJ, Nelsen LL, et al: Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114: 370-378, 2004. (Pubitemid 39071609)
23. Clark KA, McElhinny AS, Beckerle MC and Gregorio CC: Striated muscle cytoarchitecture: an intricate web of form and function. Annu Rev Cell Dev Biol 18: 637-706, 2002. (Pubitemid 35387364)
24. Karayiannakis AJ, Syrigos KN, Polychronidis A, Pitiakoudis M, Bounovas A and Simopoulos K: Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients. Anticancer Res 21: 1355-1358, 2001. (Pubitemid 32494146)
25. Matthys P, Dijkmans R, Proost P, et al: Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells. Int J Cancer 49: 77-82, 1991.
26. Lecker SH, Solomon V, Mitch WE and Goldberg AL: Muscle protein breakdown and the critical role of the ubiquitinproteasome pathway in normal and disease states. J Nutr 129: S227-S237, 1999.
27. Eley HL and Tisdale MJ: Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. J Biol Chem 282: 7087-7097, 2007. (Pubitemid 47093637)
28. Tisdale MJ: Mechanisms of cancer cachexia. Physiol Rev 89: 381-410, 2009.
29. Khal J, Hine AV, Fearon KC, Dejong CH and Tisdale MJ: Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. Int J Biochem Cell Biol 37: 2196-2206, 2005. (Pubitemid 41206831)